All In Biotech

Free tool

FAERS Monitor: Zortress

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021560 or its brand name (Zortress, Everolimus). Reports on generic versions are filed under their own applications.

Reports

18,496

Serious

16,082

87% of reports

Hospitalization

7,003

Death reported

2,839

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • malignant neoplasm progression1,602
  • off label use1,422
  • diarrhoea1,307
  • drug ineffective1,035
  • death916
  • fatigue898
  • nausea816
  • product use in unapproved indication764
  • disease progression762
  • dyspnoea704
  • pyrexia682
  • pneumonia667
  • vomiting656
  • anaemia573
  • drug interaction564

Reports by year received

View as table
YearReports
20042
20065
200715
200833
200988
2010120
2011362
2012457
2013428
2014501
2015744
2016722
2017825
20181,244
20191,401
20201,934
20211,624
20221,780
20231,834
20241,800
20251,391
20261,186

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,035,663 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
malignant neoplasm progressionSignal1,60218.117.225,513
disease progressionSignal7627.46.94,181
drug interactionSignal5644.13.71,300
product use in unapproved indicationSignal7643.53.31,383
anaemiaSignal5733.43.2987
pneumoniaSignal6672.32.2520
diarrhoeaSignal1,3072.32.2993
pyrexiaSignal6822.22.1476
off label use1,4221.81.8576
vomiting6561.61.5145
dyspnoea7041.41.387
fatigue8981.31.269
death9161.21.134
nausea8161.21.121
drug ineffective1,0350.90.814

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.